What is Ginkgo Bioworks Holdings, Inc.'s Market Cap?

Ginkgo Bioworks Holdings, Inc.'s Market Cap is $467.3M, based on as-reported figures from SEC (XBRL) filings.

What is Ginkgo Bioworks Holdings, Inc.'s Enterprise Value?

Ginkgo Bioworks Holdings, Inc.'s Enterprise Value is $165.2M, based on as-reported figures from SEC (XBRL) filings.

What is Ginkgo Bioworks Holdings, Inc.'s Price / Sales?

Ginkgo Bioworks Holdings, Inc.'s Price / Sales is 3.5×, based on as-reported figures from SEC (XBRL) filings.

What is Ginkgo Bioworks Holdings, Inc.'s EV / Revenue?

Ginkgo Bioworks Holdings, Inc.'s EV / Revenue is 1.2×, based on as-reported figures from SEC (XBRL) filings.

What is Ginkgo Bioworks Holdings, Inc.'s EV / EBITDA?

Ginkgo Bioworks Holdings, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Ginkgo Bioworks Holdings, Inc.'s Revenue (TTM)?

Ginkgo Bioworks Holdings, Inc.'s Revenue (TTM) is $132.4M, based on as-reported figures from SEC (XBRL) filings.

What is Ginkgo Bioworks Holdings, Inc.'s Net Income (TTM)?

Ginkgo Bioworks Holdings, Inc.'s Net Income (TTM) is -$290.8M, based on as-reported figures from SEC (XBRL) filings.

What is Ginkgo Bioworks Holdings, Inc.'s EBITDA?

Ginkgo Bioworks Holdings, Inc.'s EBITDA is -$252.0M, based on as-reported figures from SEC (XBRL) filings.

What is Ginkgo Bioworks Holdings, Inc.'s Diluted EPS (TTM)?

Ginkgo Bioworks Holdings, Inc.'s Diluted EPS (TTM) is -4.32, based on as-reported figures from SEC (XBRL) filings.

What is Ginkgo Bioworks Holdings, Inc.'s EBITDA Margin?

Ginkgo Bioworks Holdings, Inc.'s EBITDA Margin is -190.3%, based on as-reported figures from SEC (XBRL) filings.

Ginkgo Bioworks Holdings, Inc. (DNA) Financial Statements

Ginkgo Bioworks Holdings, Inc.

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00YPS1LT7

XNYS · usd

6.94▼ 0.01 (-0.14%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close6.95

Day's Range6.75 – 7.06

52-Week Range5.37 – 17.58

Volume1.1M

Avg Volume1.2M

Share Statistics

Shares Outstanding

Employees485

ExchangeXNYS

Listed2021-04-19

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Ginkgo Bioworks Holdings, Inc. (DNA)

What is Ginkgo Bioworks Holdings, Inc.'s Market Cap?: Ginkgo Bioworks Holdings, Inc.'s Market Cap is $467.3M, based on as-reported figures from SEC (XBRL) filings.
What is Ginkgo Bioworks Holdings, Inc.'s Enterprise Value?: Ginkgo Bioworks Holdings, Inc.'s Enterprise Value is $165.2M, based on as-reported figures from SEC (XBRL) filings.
What is Ginkgo Bioworks Holdings, Inc.'s Price / Sales?: Ginkgo Bioworks Holdings, Inc.'s Price / Sales is 3.5×, based on as-reported figures from SEC (XBRL) filings.
What is Ginkgo Bioworks Holdings, Inc.'s EV / Revenue?: Ginkgo Bioworks Holdings, Inc.'s EV / Revenue is 1.2×, based on as-reported figures from SEC (XBRL) filings.
What is Ginkgo Bioworks Holdings, Inc.'s EV / EBITDA?: Ginkgo Bioworks Holdings, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Ginkgo Bioworks Holdings, Inc.'s Revenue (TTM)?: Ginkgo Bioworks Holdings, Inc.'s Revenue (TTM) is $132.4M, based on as-reported figures from SEC (XBRL) filings.
What is Ginkgo Bioworks Holdings, Inc.'s Net Income (TTM)?: Ginkgo Bioworks Holdings, Inc.'s Net Income (TTM) is -$290.8M, based on as-reported figures from SEC (XBRL) filings.
What is Ginkgo Bioworks Holdings, Inc.'s EBITDA?: Ginkgo Bioworks Holdings, Inc.'s EBITDA is -$252.0M, based on as-reported figures from SEC (XBRL) filings.
What is Ginkgo Bioworks Holdings, Inc.'s Diluted EPS (TTM)?: Ginkgo Bioworks Holdings, Inc.'s Diluted EPS (TTM) is -4.32, based on as-reported figures from SEC (XBRL) filings.
What is Ginkgo Bioworks Holdings, Inc.'s EBITDA Margin?: Ginkgo Bioworks Holdings, Inc.'s EBITDA Margin is -190.3%, based on as-reported figures from SEC (XBRL) filings.